Phylodynamic Analysis of HIV Transmission Clusters in Kazakhstan for Targeted Interventions
对哈萨克斯坦艾滋病毒传播群进行系统动力学分析以进行有针对性的干预
基本信息
- 批准号:10212364
- 负责人:
- 金额:$ 6.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAfricaAsiansAutomobile DrivingAwardBase SequenceBehaviorBehavioralBlood specimenCentral AsiaCharacteristicsClinicalCluster AnalysisCollaborationsCollectionCommunitiesComputer AnalysisConsentDNADNA SequenceDataDatabasesDrug resistanceDrug usageEpidemicEpidemiologyExhibitsFemaleFutureGenderGenesGeneticGenetic VariationGenotypeGoalsGovernmentGrantHIVHIV InfectionsHIV SeropositivityHIV drug resistanceHIV-1Harm ReductionHeterosexualsInfectionInjectableInjecting drug userInternationalInterventionKazakhstanLinkMeasuresMigrantModelingMolecularMolecular EpidemiologyMolecular VirologyMovementMutationNeedle SharingParticipantPatternPersonsPhylogenetic AnalysisPopulationPopulations at RiskPrevalencePreventionPrevention programQuestionnairesRNARecombinantsRecording of previous eventsResearchResistanceResourcesRiskRisk BehaviorsRisk FactorsRisk ReductionSamplingScienceServicesSexual PartnersSourceStatistical ModelsStructureSubgroupTimeTimeLineTravelUniversitiesVariantWomanbasecentral databasedemographicsdisorder controldisorder preventiondrug resistant virushigh riskhigh risk behaviorhigh risk populationinnovationinsightmalemen who have sex with menmolecular sequence databaseopen sourcepol genesprofiles in patientsprogramsprophylacticprospectivereconstructionskillssocialsociodemographicsspatiotemporaltooltransmission processtrendviral RNAvirus genetics
项目摘要
PROJECT SUMMARY
The HIV epidemic in Central Asia, including Kazakhstan was originally confined largely to persons who inject
drugs (PWID), but is now spreading through sexual- and migrant-associated transmissions. Central Asia
represents the world's most rapidly growing HIV epidemic region. Phylogenetic transmission clusters,
composed of genetically similar HIV sequences (<1.5% diversity), represent recently-acquired/rapidly-
transmitting infections (transmission “hotspots”). Our objective is to identify PWID-associated currently at-risk
populations, sothey may be linked to services expeditiously.Our specific aims are: 1. Obtain sequences
from well-characterized Kazakhstani HIV-infected blood samples from PWID and other high risk
persons for phylodynamic and statistical modeling of HIV transmission clusters: To achieve this we will:
a) Analyze previously generated 800 HIV pol sequences, and prospectively collect 400 blood samples, from
consenting HIV-positive PWID and other high-risk groups, including men who have sex with men (MSM),
heterosexuals, and male/female sexual partners; b) Administer a validated questionnaire to 400 consenting
participants to characterize gender, sexual/social contacts, travel history, and risk behaviors; c) Include the
same data for the above-mentioned 800 HIV historic samples collected and previously characterized by our
collaborators; d) Extract HIV RNA/DNA from the prospective blood samples to carry out amplification and
sequencing of the HIV pol gene. 2. We will use these HIV DNA sequences and linked questionnaire data
to identify PWID-associated HIV transmission clusters and common clinical, sociodemographic and
behavioral characteristics to focus resources towards the most relevant settings/high-risk behaviors. These
clusters will be elucidated by: a) Using phylogenetic analysis to identify HIV subtypes/recombinant forms; b)
Determining profiles of drug resistance and trends of its spatiotemporal transmission; c) Using genetic
distance to the closest sequence as a measure of clustering and questionnaire data to identify subpopulations
exhibiting rapid transmission; d) Using our prospectively generated 400 HIV sequences along with historic 800
Kazakhstani (and central Asian sequences obtained from open-access databases) to determine whether
identified transmission clusters are newly emerging and/or rapidly expanding, and e) Inferring intra-Kazakhstan
and Central Asian movements of HIV-1 by applying structured coalescent phylogenetic models. These
analyses will be cross-confirmed using the open-source near real-time tracking platform, nextHIV, that
performs automated alignment, subtyping, genotypic resistance determination, phylogenetic reconstruction and
genetic distance clustering. The ultimate goal of our R03 small grant is to provide evidence regarding
transmission hotspots that will help target emerging/expanding transmission clusters, stimulating both HIV
control and prevention, and HIV molecular virology research in Kazakhstan and elsewhere in Central Asia.
项目概要
包括哈萨克斯坦在内的中亚地区的艾滋病毒流行最初主要局限于注射者
毒品(注射吸毒者),但现在正在通过性传播和移民相关的中亚传播。
代表世界上增长最快的艾滋病毒流行区域。
由遗传相似的 HIV 序列(<1.5% 多样性)组成,代表最近获得/快速-
传播感染(传播“热点”)。我们的目标是确定目前存在与吸毒者相关的风险。
人群,以便他们可以迅速与服务联系起来。我们的具体目标是: 1. 获取序列
来自吸毒者和其他高风险人群的经过充分鉴定的哈萨克斯坦艾滋病毒感染者血液样本
艾滋病毒传播集群的系统动力学和统计模型的人员:为了实现这一目标,我们将:
a) 分析之前生成的 800 个 HIV pol 序列,并前瞻性地收集 400 个血液样本,
同意 HIV 阳性吸毒者和其他高危人群,包括男男性行为者 (MSM),
异性恋者和男性/女性性伴侣;b) 对 400 名同意的人进行经过验证的调查问卷
参与者描述性别、性/社会接触、旅行史和风险行为;
我们之前收集并表征的上述 800 个 HIV 历史样本的相同数据
d) 从预期的血液样本中提取 HIV RNA/DNA 进行扩增和
HIV pol 基因测序 2. 我们将使用这些 HIV DNA 序列和关联的问卷数据。
确定与吸毒者相关的艾滋病毒传播集群以及常见的临床、社会人口学和
行为特征,将资源集中到最相关的环境/高风险行为。
将通过以下方式阐明簇: a) 使用系统发育分析来识别 HIV 亚型/重组形式;
确定耐药性概况及其时空传播趋势 c) 利用遗传;
到最近序列的距离作为聚类和问卷数据的衡量标准,以识别亚群
d) 使用我们预期生成的 400 个 HIV 序列以及历史上的 800 个序列
哈萨克斯坦(以及从开放获取数据库获得的中亚序列)以确定是否
已确定的传播集群是新出现和/或迅速扩大的,并且 e) 推断哈萨克斯坦内部
通过应用结构化合并系统发育模型研究 HIV-1 的中亚运动。
分析将使用开源近实时跟踪平台 nextHIV 进行交叉确认,
执行自动比对、亚型分析、基因型抗性测定、系统发育重建和
我们 R03 小额资助的最终目标是提供有关遗传距离聚类的证据。
传播热点将有助于瞄准新兴/扩大的传播集群,刺激艾滋病毒
哈萨克斯坦和中亚其他地区的控制和预防以及艾滋病毒分子病毒学研究。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes.
使用进化保守的 T 细胞和 B 细胞表位设计多亚基 SARS-CoV-2 疫苗。
- DOI:
- 发表时间:2021-06-26
- 期刊:
- 影响因子:7.8
- 作者:Akbay, Burkitkan;Abidi, Syed Hani;Ibrahim, Mahmoud A A;Mukhatayev, Zhussipbek;Ali, Syed
- 通讯作者:Ali, Syed
HBV Prevention and Treatment in Countries of Central Asia and the Caucasus.
中亚和高加索国家的乙型肝炎预防和治疗。
- DOI:
- 发表时间:2020-09-30
- 期刊:
- 影响因子:0
- 作者:Amerzhanov, Daulet;Suleimenova, Indira;Davlidova, Salima;Nugmanova, Zhamilya;Ali, Syed
- 通讯作者:Ali, Syed
HBV S antigen evolution in the backdrop of HDV infection affects epitope processing and presentation.
HDV 感染背景下的 HBV S 抗原进化影响表位加工和呈递。
- DOI:
- 发表时间:2021-06
- 期刊:
- 影响因子:12.7
- 作者:Sajjad, Mehwish;Ali, Syed;Baig, Samina;Sharafat, Shaheen;Khan, Bilal Ahmed;Khan, Saeed;Mughal, Nouman;Abidi, Syed Hani
- 通讯作者:Abidi, Syed Hani
Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase.
重新利用泊沙康唑和格拉佐韦作为 SARS-CoV-2 解旋酶抑制剂的潜力。
- DOI:
- 发表时间:2021-05-13
- 期刊:
- 影响因子:4.6
- 作者:Abidi, Syed Hani;Almansour, Nahlah Makki;Amerzhanov, Daulet;Allemailem, Khaled S;Rafaqat, Wardah;Ibrahim, Mahmoud A A;la Fleur, Philip;Lukac, Martin;Ali, Syed
- 通讯作者:Ali, Syed
Origin and evolution of HIV-1 subtype A6.
HIV-1 A6 亚型的起源和进化。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Abidi, Syed Hani;Aibekova, Lazzat;Davlidova, Salima;Amangeldiyeva, Aidana;Foley, Brian;Ali, Syed
- 通讯作者:Ali, Syed
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Syed Ali其他文献
Syed Ali的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Syed Ali', 18)}}的其他基金
Molecular Virology/Epidemiology HIV Training in Kazakhstan (MoVE-Kaz)
哈萨克斯坦分子病毒学/流行病学艾滋病毒培训 (MoVE-Kaz)
- 批准号:
10689586 - 财政年份:2023
- 资助金额:
$ 6.4万 - 项目类别:
Phylodynamic Analysis of HIV Transmission Clusters in Kazakhstan for Targeted Interventions
对哈萨克斯坦艾滋病毒传播群进行系统动力学分析以进行有针对性的干预
- 批准号:
10074940 - 财政年份:2020
- 资助金额:
$ 6.4万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Projecting the age shift in HIV prevalence in sub-Saharan Africa: a necessary epidemiologic step to prepare for the silver tsunami
预测撒哈拉以南非洲艾滋病毒流行率的年龄变化:应对银色海啸的必要流行病学步骤
- 批准号:
10762075 - 财政年份:2023
- 资助金额:
$ 6.4万 - 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 6.4万 - 项目类别:
Nutritional Interventions to End Tuberculosis among persons with HIV in India (NUTRIENT-India)
通过营养干预措施消除印度艾滋病毒感染者的结核病(NUTRIENT-India)
- 批准号:
10619776 - 财政年份:2023
- 资助金额:
$ 6.4万 - 项目类别:
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
HIV 艾滋病临床试验网络的支持服务
- 批准号:
10872942 - 财政年份:2023
- 资助金额:
$ 6.4万 - 项目类别:
MyPrEP Plus: Development and Pilot Testing of Novel Pre-Exposure Prophylaxis Support Tools for Transgender Women
MyPrEP Plus:针对跨性别女性的新型暴露前预防支持工具的开发和试点测试
- 批准号:
10618102 - 财政年份:2023
- 资助金额:
$ 6.4万 - 项目类别: